Poultry Vaccines Market – By Product (Attenuated Live, Inactivated, Recombinant), Disease Type (Newcastle Disease, Infectious Bronchitis), Application (Breeder, Layer, Broiler), Dosage Form (Liquid, Freeze-dried), End-user, Global Forecast (2024 – 2032)

Poultry Vaccines Market Size

Poultry Vaccines Market size was valued at USD 2.3 billion in 2023 and is poised to witness significant growth at 7.1% CAGR between 2024 and 2032. This expansion is attributed to the rising demand for poultry products, including meat and eggs, due to population growth and increasing protein consumption globally. The shift towards protein-rich diets, especially in emerging economies, has led to greater investment in poultry farming, thereby driving the demand for effective disease prevention measures, including animal vaccines.
 

The frequent outbreaks of infectious diseases in poultry, such as avian influenza and Newcastle disease, have underscored the need for robust vaccination programs. These diseases can cause significant economic losses to the poultry industry, making prevention through vaccination a critical priority. Additionally, increased awareness and education among poultry farmers about the benefits of vaccination and biosecurity measures, supported by government and international initiatives, have further encouraged the adoption of poultry vaccines. The combined impact of these factors continues to drive the expansion and diversification of the poultry vaccines market.
 

Poultry vaccines are biological preparations that stimulate an immune response in birds, such as chickens, turkeys, and ducks, to protect them against infectious diseases. These vaccines can contain live or inactivated forms of pathogens and are administered to prevent diseases like Newcastle disease, avian influenza, and Marek's disease. The use of poultry vaccines is essential in poultry farming to maintain flock health, reduce economic losses, and ensure food safety by preventing the spread of infectious agents.
 

Poultry Vaccines Market Trends

• The rising demand for poultry products is a major driver of the market, significantly influenced by projections from the Food and Agriculture Organization (FAO) and the Organization for Economic Co-operation and Development (OECD). According to their forecasts, global poultry meat consumption is expected to grow by 15% over the next decade, reaching an estimated 91 million tons by 2032.
   
• With the growing awareness of food safety and quality among consumers adds to the demand for comprehensive poultry health management practices, including vaccination.
   
• As a result, the poultry industry invests more in comprehensive vaccination programs to safeguard the health of their flocks, thereby driving the growth of the market.
   

Poultry Vaccines Market Analysis

Based on product, the market is segmented into attenuated live vaccines, inactivated vaccines, recombinant vaccines, and other vaccine types. The attenuated live vaccines dominated the global poultry vaccines and is anticipated to grow at 6.9% over the forecast period.
 

• The attenuated live vaccines segment leads the market due to its ability to induce a strong and long-lasting immune response.
   
• They also offer a rapid onset of immunity, crucial for protecting young birds or responding to outbreaks.
   
• The production and administration of these vaccines are cost-effective and flexible, often requiring fewer doses and are suitable for large-scale poultry operations.
   
• These factors collectively make attenuated live vaccines the preferred choice in the poultry industry, driving their leading market share.
   

Based on disease type, the poultry vaccines market is categorized into Newcastle disease, infectious bronchitis, infectious bursal diseases, salmonella, Marek's disease, egg drop syndrome, adenovirus, coccidiosis, avian influenza, infectious laryngotracheitis, avian encephalomyelitis, and other disease types. The Newcastle disease segment accounted for highest market share of 20.8% in 2023.
 

• The high prevalence and virulence, with strains ranging from mild to highly virulent, result in severe impacts on poultry health and productivity, making vaccination an essential preventive measure.
   
• Thus, the outbreaks of Newcastle disease cause significant economic losses, including high mortality rates, reduced egg production, and decreased growth rates, leading to increased culling of infected birds. These economic repercussions drive the demand for effective vaccines to mitigate financial losses in the poultry industry.
   
• Furthermore, the availability of a diverse range of vaccines, including live attenuated, inactivated, and recombinant types, allows for flexible vaccination strategies tailored to different farming systems and disease risks.

Based on application, the poultry vaccines market is classified into breeder, layer, and broiler. The breeder segment was valued at USD 883.9 million in 2023.
 

• The breeder segment dominates the market due to its crucial role in preserving flock health and ensuring consistent productivity. Breeder flocks are vital for producing hatching eggs and future generations, which makes their health a primary concern. Consequently, increasing awareness about the importance of breeder stock health significantly fuels growth in this segment.
   
• Moreover, biosecurity protocols and regulatory requirements further drive the demand for vaccines in breeder operations. Vaccination plays a key role in biosecurity, helping to prevent the introduction and spread of diseases and thereby maintaining flock stability.
   
• These factors reinforce the segment's leading position in the market by underscoring the essential nature of effective vaccination in breeder management.
   

Based on dosage form, the poultry vaccines market is bifurcated into liquid vaccine and freeze-dried vaccine. The liquid vaccine is projected to reach USD 2.3 billion by 2032.
 

• The liquid dosage form has a long history of use and proven efficacy in poultry vaccination. Its established track record builds confidence among poultry producers and veterinarians, leading to widespread adoption and dominance in the market.
   
• Liquid vaccines often offer cost advantages due to their ability to cover large numbers of birds with a single batch. This is particularly beneficial for large-scale poultry farms, where economies of scale are crucial for managing operational costs, thereby driving growth of the liquid vaccine segment.
   

Based on end-user, the poultry vaccines market is categorized into veterinary hospitals & clinics, and poultry farms. The poultry farms segment is expected to witness growth at 6.8% from 2024 - 2032.
 

• The highest growth of the segment can be attributed to its large-scale operations and the critical need for comprehensive vaccination programs. Large commercial poultry farms require extensive vaccination to protect their significant flocks from a range of diseases.
   
• Moreover, regular vaccination helps maintain optimal health and productivity of poultry flocks by preventing diseases that can impact growth rates, egg production, and overall performance.
   
• Thus, these factors collectively drive the dominance of the poultry farms segment in the market, as effective vaccination is critical for managing large flocks, ensuring biosecurity, and maintaining economic viability.

North America poultry vaccines market dominated the global market and is expected to grow at 7% to reach USD 1.7 billion by 2032.
 

• North America, particularly the US and Canada, has a highly developed poultry industry with advanced farming practices and technologies. This includes sophisticated vaccination programs and biosecurity measures that contribute to the market's dominance and growth.
   
• North America is a hub for innovation in vaccine development and delivery systems. Ongoing research and development efforts in vaccine technology, including advancements in vaccine efficacy and delivery methods, enhance market growth prospects.
   

The U.S. poultry vaccines market size accounted for USD 851.9 million and is anticipated to reach USD 1.5 billion by 2032.
 

• The US, according to World Population Review, leads global chicken consumption, with approximately 15,000 metric tons consumed annually. This high level of consumption underscores the significant role poultry plays in the American diet, driving substantial demand for poultry products.
   
• As a result, there is a strong need for effective disease management and vaccination programs to maintain flock health and productivity. This high consumption rate directly influences the U.S. market, contributing to its large market size and growth projections.
   

China poultry vaccines market is anticipated to grow at considerable rate over the next coming years.
 

• China, according to World Population Review, is the second largest consumer of chicken globally, with approximately 12,000 metric tons consumed annually. This substantial consumption level reflects a strong and growing demand for poultry products in China.
   
• Consequently, to manage disease outbreaks and enhance flock health, the demand for poultry vaccines is expected to rise, driving considerable market growth in the coming years.
   

India is expected to grow at lucratively from 2024 – 2032 in global poultry vaccines market.
 

• According to the Department of Animal Husbandry, Dairying & Fisheries, India’s per capita consumption of broiler meat is 3.35 kg per person per year. This modest consumption level indicates significant potential for growth in poultry meat demand as consumer preferences shift and incomes rise.
   
• As the Indian population increasingly incorporates poultry into their diets, the demand for broiler meat is expected to expand, necessitating improvements in poultry health and production.
   
• This growth will be driven by the expanding poultry industry, regulatory requirements, and the need to safeguard against disease outbreaks to meet rising consumer demand for poultry products.
   

Poultry Vaccines Market Share

The market is characterized by significant competition among major players such as Zoetis Inc., Merck, Boehringer Ingelheim, and Elanco Animal Health, known for their extensive vaccine portfolios and innovation. Key strategies include significant investment in R&D to enhance vaccine efficacy, strategic mergers, and acquisitions to expand market presence, and collaborations to improve product offerings. Companies are also focusing on geographical expansion into emerging markets, driving overall market growth and innovation.
 

Poultry Vaccines Market Companies

Prominent players operating in the poultry vaccines industry include:

• Biovac
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• HIPRA
• Merck & Co., Inc.
• Phibro Animal Health Corporation
• Vaxxinova International BV
• Venky's Limited
• Zoetis, Inc.
   

Poultry Vaccines Industry News:

• In May 2024, Merck & Co., Inc. announced that the European Commission granted marketing authorization for its INNOVAX-ND-H5 vaccine for chickens. This approval has helped the company to broaden its product offerings and generate revenue.
   
• In January 2024, Boehringer Ingelheim announced the launch of Vaxxilive Cocci 3, a poultry coccidiosis vaccine previously known as Hatchpak Cocci III. By rebranding and launching Vaxxilive Cocci 3, Boehringer Ingelheim strengthens its position in the market.
   

The poultry vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Attenuated live vaccines
• Inactivated vaccines
• Recombinant vaccines
• Other vaccine types

Market, By Disease Type

• Newcastle disease
• Infectious bronchitis
• Infectious bursal diseases
• Salmonella
• Marek's disease
• Egg drop syndrome
• Adenovirus
• Coccidiosis
• Avian influenza
• Infectious laryngotracheitis
• Avian encephalomyelitis
• Other disease types

Market, By Application

• Breeder
• Layer
• Broiler

Market, By Dosage Form

• Liquid vaccine
• Freeze dried vaccine

Market, By End-user

• Veterinary hospitals & clinics
• Poultry farms

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa